Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression-Reference-Cited by-同舟云学术

Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression

Published:2011-06 Issue:3 Volume:99 Page:323-330
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Gurtner Kristin,Deuse Yvonne,Bütof Rebecca,Schaal Katja,Eicheler Wolfgang,Oertel Reinhard,Grenman Reidar,Thames Howard,Yaromina Ala,Baumann Michael,Krause Mechthild

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference57 articles.

1. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

2. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study;Eriksen;Radiother Oncol,2005

3. Epidermal growth factor receptor expression in pretreatment biopsies from head, neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial;Bentzen;J Clin Oncol,2005

4. Epidermal growth factor receptor targeting in cancer;Mendelsohn;Semin Oncol,2006

5. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation;Schmidt-Ullrich;Oncogene,1997

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts;Radiotherapy and Oncology;2024-02

2. Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts;Journal of Translational Medicine;2023-08-26

3. Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer;Journal of Clinical Oncology;2023-08-01

4. Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models;Radiotherapy and Oncology;2023-06

5. Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting;Radiotherapy and Oncology;2022-04